These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 16396838)
1. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838 [TBL] [Abstract][Full Text] [Related]
2. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [TBL] [Abstract][Full Text] [Related]
3. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Law M; Young RJ; Babb JS; Peccerelli N; Chheang S; Gruber ML; Miller DC; Golfinos JG; Zagzag D; Johnson G Radiology; 2008 May; 247(2):490-8. PubMed ID: 18349315 [TBL] [Abstract][Full Text] [Related]
4. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608 [TBL] [Abstract][Full Text] [Related]
7. Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Essig M; Waschkies M; Wenz F; Debus J; Hentrich HR; Knopp MV Radiology; 2003 Jul; 228(1):193-9. PubMed ID: 12832582 [TBL] [Abstract][Full Text] [Related]
8. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427 [TBL] [Abstract][Full Text] [Related]
9. Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas. Spampinato MV; Schiarelli C; Cianfoni A; Giglio P; Welsh CT; Bisdas S; Rumboldt Z Neuroradiol J; 2013 Aug; 26(4):385-95. PubMed ID: 24007727 [TBL] [Abstract][Full Text] [Related]
10. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064 [TBL] [Abstract][Full Text] [Related]
11. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020 [TBL] [Abstract][Full Text] [Related]
12. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239 [TBL] [Abstract][Full Text] [Related]
14. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790 [TBL] [Abstract][Full Text] [Related]
15. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study. Majchrzak K; Kaspera W; Bobek-Billewicz B; Hebda A; Stasik-Pres G; Majchrzak H; Ładziński P Clin Neurol Neurosurg; 2012 Oct; 114(8):1135-44. PubMed ID: 22425370 [TBL] [Abstract][Full Text] [Related]
16. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. Young R; Babb J; Law M; Pollack E; Johnson G J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374 [TBL] [Abstract][Full Text] [Related]
17. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. Caseiras GB; Chheang S; Babb J; Rees JH; Pecerrelli N; Tozer DJ; Benton C; Zagzag D; Johnson G; Waldman AD; Jäger HR; Law M Eur J Radiol; 2010 Feb; 73(2):215-20. PubMed ID: 19201123 [TBL] [Abstract][Full Text] [Related]
18. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Warmuth C; Gunther M; Zimmer C Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338 [TBL] [Abstract][Full Text] [Related]
19. Correlation between dynamic contrast-enhanced perfusion MRI relative cerebral blood volume and vascular endothelial growth factor expression in meningiomas. Ginat DT; Mangla R; Yeaney G; Schaefer PW; Wang H Acad Radiol; 2012 Aug; 19(8):986-90. PubMed ID: 22591719 [TBL] [Abstract][Full Text] [Related]
20. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]